MLchartDataset catalogue

EPOCH-O regimen

Term · Oncology and biomedicine · MLC-T-ONC-013392

An immune-chemotherapy regimen consisting of etoposide, prednisone, vincristine (Oncovin), cyclophosphamide, doxorubicin (hydroxydaunorubicin) and ofatumumab, which may be used for the treatment of various aggressive non-Hodgkin lymphomas.

Table 1. Record
IdentifierMLC-T-ONC-013392
FieldOncology and biomedicine
AbbreviationEPOCH-O
SynonymsO-EPOCH regimen; O-EPOCH; etoposide-prednisone-Oncovin-cyclophosphamide-hydroxydaunorubicin-ofatumumab regimen; EPOCH plus Arzerra; EPOCH plus ofatumumab; dose-adjusted EPOCH-ofatumumab; dose-adjusted etoposide-prednisone-vincristine-cyclophosphamide-ofatumumab; DA EPOCH-O; dose-adjusted etoposide/vincristine/doxorubicin/cyclophosphamide/prednisone plus ofatumumab regimen
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013392",
  "term": "EPOCH-O regimen",
  "field": "Oncology and biomedicine",
  "definition": "An immune-chemotherapy regimen consisting of etoposide, prednisone, vincristine (Oncovin), cyclophosphamide, doxorubicin (hydroxydaunorubicin) and ofatumumab, which may be used for the treatment of various aggressive non-Hodgkin lymphomas.",
  "abbreviation": "EPOCH-O",
  "synonyms": [
    "O-EPOCH regimen",
    "O-EPOCH",
    "etoposide-prednisone-Oncovin-cyclophosphamide-hydroxydaunorubicin-ofatumumab regimen",
    "EPOCH plus Arzerra",
    "EPOCH plus ofatumumab",
    "dose-adjusted EPOCH-ofatumumab",
    "dose-adjusted etoposide-prednisone-vincristine-cyclophosphamide-ofatumumab",
    "DA EPOCH-O",
    "dose-adjusted etoposide/vincristine/doxorubicin/cyclophosphamide/prednisone plus ofatumumab regimen"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/epoch-o-regimen/"
}

Record 6,802 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.